Back to companies

Samsung Biologics Co Ltd: Deals

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $125 per month (billed Annually)
Signup to View Free Sample

View up-to-date information on Samsung Biologics Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Find out more

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
January 27, 2022 Samsung Biologics Acquires Remaining Stake in Samsung Bioepis from Biogen Acquisition Samsung Biologics Co Ltd Samsung Bioepis Co Ltd
August 13, 2020 Samsung Bioepis Co Ltd Enters Phase I Clinical Trial Agreement with Parexel International Corp for adalimumab biosimilar (GDCT0396216) Contract Service Agreement Samsung Bioepis Co Ltd;Samsung Bioepis Co Ltd Parexel International Corp;Parexel International Corp
June 23, 2020 Samsung Bioepis Co Ltd Enters Phase III Clinical Trial Agreement with Parexel International Corp for aflibercept biosimilar (GDCT0386792) Contract Service Agreement Samsung Bioepis Co Ltd;Samsung Bioepis Co Ltd Parexel International Corp;Parexel International Corp
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you subscribe Explore the latest deals, partnerships, mergers & acquisitions when you subscribe Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer